OCX Oncocyte Corp

OncoCyte Corp focuses on the discovery, development, and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer.

$5.50  -0.11 (-1.96%)
As of 06/22/2021 15:59:54 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  12/30/2015
Outstanding shares:  89,868,418
Average volume:  456,174
Market cap:   $479,897,352
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    68235C107
ISIN:        US68235C1071
Sedol:      BYQRGG0

---

Valuation   (See tab for details)

---

PE ratio:   -19.30
PB ratio:   4.68
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%